Yun Feng

Yun Feng is a seasoned scientist with extensive experience in cell biology and assay development. Currently serving as a Principal Scientist at Delphia Therapeutics since May 2023, Yun previously held the position of Associate Principal Scientist at KSQ Therapeutics, Inc., where leadership in cell-based assay development for Immuno-oncology targets was a primary focus. Prior roles at Novartis Institutes for BioMedical Research included progression through various titles, culminating as Principal Scientist I, while earlier experience involved research technician duties at the MIT Center for Cancer Research and a scientist role at Genome Therapeutics Corporation. Yun holds an M.S. in Molecular Genetics from Syracuse University and a B.S. in Biochemistry from Nankai University.